JPMorgan Upgrades The Medicines Company (MDCO) to Overweight
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Intra-day, JPMorgan upgraded The Medicines Company (NASDAQ: MDCO) from Neutral to Overweight.
For an analyst ratings summary and ratings history on The Medicines Company click here. For more ratings news on The Medicines Company click here.
Shares of The Medicines Company closed at $22.29 yesterday.
For an analyst ratings summary and ratings history on The Medicines Company click here. For more ratings news on The Medicines Company click here.
Shares of The Medicines Company closed at $22.29 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Brean Capital Upgrades Columbia Financial Inc (CLBK) to Buy
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
